Castle Biosciences, Inc. (CSTL) Earnings Per Share (EPS)
Castle Biosciences, Inc. (CSTL) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2019-12-31 | $0.35 |
| 2020-12-31 | -$0.54 |
| 2021-12-31 | -$1.24 |
| 2022-12-31 | -$2.58 |
| 2023-12-31 | -$2.14 |
| 2024-12-31 | $0.66 |
| 2025-12-31 | -$0.83 |
How CSTL compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| STIM | Neuronetics Inc. | -$0.59 |
| GOSS | Gossamer Bio Inc. | -$0.75 |
| ALT | Altimmune Inc. | -$1.00 |
| RFL | Rafael Holdings Inc. Class B | -$1.04 |
| IOVA | Iovance Biotherapeutics Inc. | -$1.09 |
These are five companies in the same sector as CSTL with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Castle Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("CSTL")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CSTL | $32.91 | +0.80% | 0.19M |
| 3 | ||||
| 4 | ||||
| 5 |